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Objective: To compare the predictive capacity of self-reported somatic symptoms and mood
(depression and anxiety) on health-related quality of life (HRQoL) in patients with chronic
renal disease.
Method: Data were obtained from 52 patients undergoing haemodialysis. Measures included
(a)  the SF-36 health survey, (b) the somatic symptoms scale revised (ESS-R) and (c) the hos-
pital anxiety and depression scale (HADS). Multiple regression was the main method of
statistical analysis.
Results: Patients exhibited HRQoL levels below normative values, with anxiety and depres-
sion prevalence at 36.5% and 27%, respectively. Mood was the strongest predictor of physical
(ˇ  = −.624) and mental (  ˇ = −.709) HRQoL. Somatic symptoms were also associated with
physical HRQoL, but their predictive value was weaker (  ˇ = −.270).
Conclusions: These results indicate that mood is a superior predictor of the physical and
mental components of HRQoL in patients compared with the number and severity of phys-
ical  symptoms. The data underline the importance of assessing negative emotional states
(depression and anxiety) in kidney patients as a basis for intervention, which may facilitate
reduction of the impact of chronic renal disease on HRQoL.©  2016 Sociedad Espan˜ola de Nefrologı´a. Published by Elsevier Espan˜a, S.L.U. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/). Please cite this article as: Perales Montilla CM, Duschek S, Reyes del Paso GA. Calidad de vida relacionada con la salud en la enfermedad
enal crónica: relevancia predictiva del estado de ánimo y la sintomatología somática. Nefrologia. 2016;36:275–282.
∗ Corresponding author.
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013-2514/© 2016 Sociedad Espan˜ola de Nefrologı´a. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the CC
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
276  n e f r o l o g i a. 2 0 1 6;3 6(3):275–282
Calidad  de  vida  relacionada  con  la  salud  en  la  enfermedad  renal  crónica:
relevancia  predictiva  del  estado  de  ánimo  y  la  sintomatología  somática
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r  e  s  u  m  e  n
Objetivo: Comparar la capacidad predictiva de los síntomas somáticos informados y el estado
anímico (depresión y ansiedad) sobre la calidad de vida relacionada con la salud (CVRS) en
pacientes con enfermedad renal crónica.
Método: Se evaluó a 52 pacientes en tratamiento de hemodiálisis mediante: a) la escala de
funcionamiento y calidad de vida (SF-36), b) la escala de síntomas somáticos-revisada (ESS-
R)  y c) la escala de ansiedad y depresión en hospital (HAD). Los datos fueron analizados
mediante análisis de regresión múltiple.
Resultados: Los pacientes mostraron niveles de CVRS inferiores a los valores normativos
del  instrumento, así como un 36,5% de prevalencia de ansiedad y un 27% de depresión. El
estado anímico fue el predictor más signiﬁcativo de la CVRS, tanto en su componente físico
(ˇ  = −0,624) como mental (  ˇ = −0,709). Los síntomas somáticos predijeron, con menor fuerza
asociativa, el componente de salud física (  ˇ = −0,270).
Conclusiones: El estado anímico es un mejor predictor de los componentes físico y mental de
la  CVRS que el número e intensidad de los síntomas físicos informados por los pacientes.
Estos resultados sen˜alan la importancia de evaluar e intervenir sobre los estados emo-
cionales negativos (depresión y ansiedad) en los pacientes renales. Estas intervenciones
pueden repercutir en una menor interferencia de la enfermedad sobre la CVRS en el paciente
en hemodiálisis.
©  2016 Sociedad Espan˜ola de Nefrologı´a. Publicado por Elsevier Espan˜a, S.L.U. Este es un
artı´culo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/Introduction
Health-related quality of life (HRQoL) has been deﬁned as
the evaluation made by the individual regarding his or her
health and level of functioning in going about day-to-day
activities, including physical, psychological and social func-
tion; general perception of health; mobility; and emotional
well-being.1,2 HRQoL has become an essential concept for
comprehensive care of the patient with a chronic disease.2,3
It is a useful variable for predicting potential adverse con-
sequences in the course of the disease and for evaluating
treatment efﬁcacy.4 The HRQoL measurement is being used
to evaluate the repercussions and impact that the disease
causes in patients’ day-to-day life. It provides additional infor-
mation of major importance to the simple diagnosis of the
disease.5
Several studies have evaluated HRQoL in chronic kid-
ney disease (CKD) and in patients on haemodialysis (HD)
treatment.1,2,6,7 These works have shown that CKD and HD
treatment interfere with the patient’s life, and that HRQoL
decreases if this is not borne in mind and addressed.2,8 The
kidney patient has a lower HRQoL than that found in the
general population,9,10 and this deterioration in HRQoL has
been associated with clinical variables,11,12 sociodemographic
variables,2,13,14 dialysis characteristics,14 physical symptoms,
social support and disease impact.4 In addition, these studies
have shown a close relationship between HRQoL indicators
and morbidity/mortality indices.7,15
Some previous works have focused on the impor-
tance of physical deterioration in the determination ofby-nc-nd/4.0/).
HRQoL.2,4,6,10,16 The kidney patient’s physical problems mod-
ulate the assessments made by the patient of his or her
adaptive capacity and condition as a sick person. The
most common symptoms reported by kidney patients are
musculoskeletal, gastrointestinal, immunological, cardiovas-
cular and skin/allergy-related.17 These symptoms could be
accounted for in part by the long-term effect of anaemia,
malnutrition, cardiovascular complications typical in the
kidney patient and complications or insufﬁcient doses of
dialysis.18 However, many  properly dialysed patients, with
good haematocrit levels and good clinical chemistry man-
agement, continue to have “widespread” physical discomfort
that affects their well-being, for which no clear aetiology is
found,14 and which does not respond appropriately to the
treatments prescribed.19 One possible explanation for these
symptoms and this “widespread” discomfort could lie in psy-
chological and emotional considerations. For example, level of
anxiety is an independent predictor of the report of somatic
symptoms. This accounts for the 25% variance in total symp-
toms reported.17 Other variables associated with the report of
somatic symptoms in the kidney patient in dialysis treatment
are depression, degree of concern and passive strategies for
coping with stress (fatalism and helplessness/hopelessness),
while level of self-efﬁcacy, social support and active coping
strategies (such as a ﬁghting spirit) are associated with lower
reports of physical symptoms.17
Several works have assigned major importance to emo-
tional disturbances in the determination of the HRQoL of the
kidney patient.10–12,20–23 These emotional disturbances may
be caused by the numerous losses the kidney patient has to
face (loss of renal function, loss of well-being, loss of place in
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Table 1 – Sociodemographic and clinical characteristics
of the sample of patients used.
Variables N %
Age (years)
20–29 2 3.8
30–39 8 15.4
40–49 27 51.9
50–60 15 28.8
Level of education
No schooling 6 11.5
Primary 30 57.7
Secondary 9 17.3
University 7 13.5
Time in dialysis (years)
0.5–5 23 44.2
6–10 17 32.7
11–20 8 15.4
≥21 4 7.7
Causes of CKD
Chronic glomerulonephritis 19 36.5
Vascular 9 17.3
Diabetes mellitus 9 17.3
Polycystic kidney disease 6 11.5
Pyelonephritis 6 11.5
Unknown 3 5.8
Previous transplantn e f r o l o g i a. 2 0 
he family and at work, loss of ﬁnancial resources and loss of
exual function), the continuous uncertainty that he or she
xperiences (regarding survival, dependence on medical tech-
ology, etc.), the stress inherent to dialysis sessions, serious
ietary restrictions, etc.
Depression is one of the factors that negatively affect
RQoL20–25 in the kidney patient. Some studies have found
hat depression is the main predictor of HRQoL21: it is neg-
tively associated with all its components and accounts for
ercentages of variance of around 50% for physical function,
hysical role, vitality, social function and mental health.10 Less
mportantly, degree of concern regarding the disease, as well
s passive strategies for coping with stress, are also asso-
iated with lower HRQoL levels.10 By contrast, self-efﬁcacy,
ptimism, social support and a ﬁghting spirit are related to
reater HRQoL levels.10 The UK National Institute for Health
nd Care Excellence has explicitly recognised the importance
f depression in kidney disease.26 Depression tends to be
ore  refractory to treatment when it occurs in the context of
nother medical disease.27,28 Thus, depression has a greater
revalence and is more  resistant to treatment in the kidney
atient in dialysis than in the general population.29
Based on the previous review, the 2 factors that seem to
ost affect the HRQoL of the kidney patient in HD treatment
re somatic symptoms and mood (depression and anxiety).
owever, we  have not found any studies that have analysed
he combined and interactive inﬂuence of these 2 factors on
he HRQoL of the kidney patient. In this context, the objective
f this study was to compare the relative predictive capac-
ty of somatic symptoms reported by the patient and his or
er mood (depression and anxiety) with respect to HRQoL in
atients with CKD in HD treatment, distinguishing between
he HRQoL subcomponents of physical health and mental
ealth. The potential interaction between somatic symptoms
nd mood in the determination of HRQoL was also analysed.
ethod
articipants
he sample included 52 patients in chronic HD (38 men  and
4 women). The type of dialysis received was on-line, 3 ses-
ions per week, 4 h each (plus one extra session to remove the
verweight of patients who had gained weight relative to the
revious session). Table 1 shows sociodemographic and clini-
al characteristics of patients included. The inclusion criteria
ere: 60 years old or younger, in treatment with dialysis for
ore  than 6 months, not having suffered from serious clini-
al situations in the last 6 months (prolonged hospital stays
r recent vascular access obstruction) and not suffering from
ny psychiatric disorder or intellectual disability. These crite-
ia were used to ensure appropriate understanding of the tools
or evaluation used and reduce the possibility of the patient’s
linical state interfering with the results. The research study
as offered to 100% of the patients available in the health
istrict (Haemodialysis Unit at Hospital Médico Quirúrgico,
entro de Hemodiálisis de Santa Catalina, NefroLinares and
entro de Diálisis Playa de la Victoria) who  met  the inclusion
riteria (59 patients). Of these, 52 (88.13%) patients ultimatelyNo 35 67.3
Yes 17 32.6
agreed to participate in the research study. Patient loss was
due to a refusal to participate by 3 patients (5.1%) and clinical
problems during the research study in 4 patients (6.7%).
Measurement  tools
The following instruments were administered:
- SF-36 Functioning and Quality-of-Life Scale,30 in the Spanish
version by Alonso, Prieto and Antó.31 This instrument eval-
uates the impact of disease on adaptive functioning and
provides a state-of-health proﬁle. It contains 36 items with
a 2-, 3-, 5- and 6-point Likert response format, depending on
the item, with a range from 0 to 100: the higher the score,
the better the state of health. It comprises 8 dimensions:
physical function, physical role, body pain, general health, vitality,
social function, emotional role and mental health.  By aggregating
these dimensions, 2 components were calculated: a physical
health component (PHC) and a mental health component
(MHC). The internal consistency (Cronbach’s ) of the dif-
ferent scales ranged between 0.7 and 0.94.31 For the PHC,
Cronbach’s  ˛ was 0.94, and for the MHC, it was 0.89.32
- Revised Somatic Symptom Scale (ESS-R).33 This instrument
evaluates physical health based on symptoms correspond-
ing to the most important somatic/physiological systems.
It contains 90 items with a 5-point Likert response for-
mat  with a range from 0 to 4: the higher the score, the
greater the symptoms. They are classiﬁed according to
the following subscales: general immunological, cardiovas-
cular, respiratory, gastrointestinal, sensorineural, skin/allergy-
related, musculoskeletal, female reproductive and genitourinary.
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Table 2 – Means and standard deviations (SDs) for HRQoL in its physical component (PHC), its mental component (MHC)
and total.
Kidney patients Spanish population Comparison of means (t-test)
Mean SD Mean SD Dif. in means t p
PHC 53.66 22.77 84.75 21.96 −31.08 −9.84 <0.0001
MHC 63.60 25.18 84.81 18.54 −21.21 −6.07 <0.0001
Total HRQoL 58.63 22.82 84.78 20.25 −26.15 −8.26 <0.0001
e valuThe results are presented as direct scores together with the referenc
of means using Student’s t test is also presented.
The latter 2 subscales were removed from the study. The
internal consistency (Cronbach’s ˛) of the different scales
ranged between 0.79 and 0.84.33
- Hospital Anxiety and Depression Scale (HAD)34 in the Span-
ish version by Caro and Ibán˜ez35. This instrument evaluates
anxiety and depression levels without taking somatic symp-
toms into account, and so it limits the possibility that
symptoms speciﬁc to the disease will contribute to scores. It
contains 14 items with a 4-point Likert response format with
a range from 0 to 3: the higher the score, the greater the anx-
iety or depression. It comprises 2 subscales: one for anxiety
and one for depression. The instrument had good internal
consistency, with a Cronbach’s  ˛ coefﬁcient of 0.82 for the
anxiety subscale and 0.84 for the depression subscale.34
Procedure
For patient selection, the dialysis centres in the Spanish
province of Jaén were contacted (see section: Participants).
Once the protocol had been approved by the sites, the nephrol-
ogists selected the patients who met  the inclusion criteria. The
objectives of the study were explained to these patients, and
those who agreed to participate signed an informed consent
form. Information on sociodemographic and clinical variables
was collected during HD sessions through an interview with
the patient. Next, a booklet with the questionnaires used in
the study was given according to a counterbalanced order.
Data was collected during the months of February to June 2014.
Statistical  analysisTo increase reliability, reduce the number of statistical anal-
yses and minimise the likelihood of a type I error, statistical
analyses were performed with the total scores for each instru-
ment. The 8 dimensions of the SF-36 were reduced to the PHC,
Table 3 – Means and standard deviations (SDs) for anxiety, dep
Anxiety 
Mean (±SD) 7.13 (4.41) 
Scale criteria Cases Percentage 
Normality 33 63.5 
Probable case 6 11.5 
Deﬁnite case 13 25 
The number and percentage of patients who met the scale’s criteria for noes in the general Spanish population. The result of the comparison
the MHC and a total score for HRQoL, based on the average of
the 2 subcomponents. A total score was obtained from the
ESS-R with the sum of all the symptoms reported. A general
score for mood was obtained from the HAD with the sum of
the scores in depression and anxiety.
The analysis of the associations between the variables con-
sidered to be predictive (somatic symptoms and mood) and the
variables identiﬁed as dependent (HRQoL in its physical com-
ponent, its mental component and total) was performed using
an exploratory correlational analysis through bivariate Pear-
son correlations and, subsequently, with a multiple regression
analysis. In the regression analysis, as a ﬁrst step, the variables
of age and time in dialysis were entered to control their effect
on the subsequent analyses. As a second step, somatic symp-
toms and mood were entered jointly. In a prior analysis, the
interaction factor of somatic symptoms × mood was calculated
and entered in the regression analyses. These analyses did
not show any interaction effect and were omitted from the
results report. To compare the HRQoL levels of the patients
with CKD in HD with those of the general Spanish population,
the difference in means between each patient’s score and the
reference values for the SF-36 in the Spanish population was
calculated.36 The difference in means obtained was analysed
using Student’s t test for one sample. The level of signiﬁcance
was set at p < 0.05. The data were analysed with the SPSS v.
19.0 statistics program.
Results
Levels  of  health-related  quality  of  life,  anxiety,  depression
and  somatic  symptoms
Table 2 shows the scores for HRQoL in its physical component,
its mental component and total, together with the reference
ression and overall mood.
Depression Overall score
5.50 (4.26) 12.63 (7.78)
Cases Percentage
38 73
7 13.5
7 13.5
rmality, probable case and deﬁnite clinical case are indicated.
n e f r o l o g i a. 2 0 1 6;3  6(3):275–282 279
Table 4 – Correlations between HRQoL in its physical
component (PHC), its mental component (MHC) and
total; mood; and total somatic symptoms.
PHC MHC Total QoL
Total symptoms –0.62* –0.57* –0.62*
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Fig. 1 – Dispersion graph and regression line for the scores
in mood and the mental health component of the SF-36.
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Fig. 2 – Dispersion graph and regression line for the scoresMood –0.76* –0.80* –0.81*
∗ p < 0.01.
alues for the Spanish population. As may be observed, the
RQoL levels shown by the patients remained below those
btained by the instrument normative sample. Moreover, the
evels shown for the PHC were signiﬁcantly lower than the
evels shown for the MHC  (t = −4.81; p < 0.0001).
Table 3 shows the scores for anxiety, depression and overall
ood. Deﬁnite and likely cases of anxiety comprised 36.5%
f the sample, while those of depression comprised 27% of
he sample evaluated. The value for total somatic symptoms
eported was 83.17, with a standard deviation of 45.51.
ivariate  correlation  analysis
able 4 shows the correlations between HRQoL in its physical
nd mental component, as well as total, with mood and total
omatic symptoms. The results showed a signiﬁcant negative
ssociation between HRQoL, mood and somatic symptoms
p < 0.01 in all the correlations). The correlations of HRQoL in
ts 3 components were higher with mood than with somatic
ymptoms.
ultiple  regression  analysis  to  predict  health-related
uality  of  life
able 5 presents the results of the multiple regression anal-
sis to predict HRQoL. Age and time in dialysis were not
igniﬁcantly associated with any of the HRQoL indicators. The
esults obtained showed that mood was the most signiﬁcant
redictor (negative association) of the 3 HRQoL indicators.
otal somatic symptoms also negatively predicted the PHC
omponent of HRQoL and overall HRQoL, but with a lower
ssociative capacity than mood. To illustrate these asso-
iations, Figs. 1 and 2 show the scatered plots and the
egression line that correlates mood to the PHC and the MHC,
Table 5 – Results of the multiple regression analysis to
predict HRQoL in its physical component (PHC), its
mental component (MHC) and total, after statistically
controlling for the inﬂuence of age and time in dialysis.
Predictive v. B r2 t p
PHC
Total symptoms −0.270 0.620 −2.56 0.014
Mood −0.624 −5.89 <0.001
MHC
Total symptoms −0.177 0.639 −1.73 0.091
Mood −0.709 −6.87 <0.001
Total QoL
Total symptoms −0.231 0.680 −2.39 0.021
Mood −0.691 −7.12 <0.001in mood and the physical health component of the SF-36.
respectively. Using a stepwise regression procedure for the 2
predictors accurately reproduced the results.
Discussion
Our main objective was to compare the predictive capacity of
somatic symptoms reported and mood with respect to HRQoL
in patients with CKD in HD. First, the possibility of there being
an interactive effect among the variables was analysed. The
results were negative: both variables exerted additive rather
than interactive effects. Given that prior studies have shown
that age and time in dialysis may affect quality of life,2,37,38 we
performed a statistical control of the effect of both variables.
Neither age nor time in dialysis was found to be signiﬁcantly
associated with HRQoL in any of the regression analyses per-
formed. One potential explanation for that may lie in the
limited range of variability for both variables in our sample.
The results of the regression analyses showed that mood
was the main predictor of HRQoL, both in the PHC and in the
MHC. Given that the association was negative, a more  negative
mood was associated with a decrease in HRQoL indicators. In
addition, with a lower degree of association, somatic symp-
toms also negatively predicted the physical component of
HRQoL and overall HRQoL. Taken together, mood and somatic
 0 1 6280  n e f r o l o g i a. 2
symptoms accounted for 68% of variance in total HRQoL, 64%
of variance in the MHC  and 62% of variance in the PHC.
Given the magnitude of the standardised  ˇ statistics observed
(between −0.624 and −0.709), these results showed convincing
evidence about the inﬂuence of mood on the determination
of quality of life. These results were consistent with those
found in prior studies that have shown the negative inﬂuence
of anxiety and depression on HRQoL.12,21–24
Our results agree with ﬁndings from previous
studies2,20,36,37,39,40 that have shown that the HRQoL lev-
els reported by patients, in both its physical component and
its mental component, are well below the reference values of
the SF-36 questionnaire in the Spanish population.36 It should
be noted that the PHC obtained an average signiﬁcantly lower
than the MHC. This indicated that patients with CKD in HD
perceive and are aware of the physical limitations deriving
from the disease,16 beyond the potential repercussions in the
social and emotional sphere. These results were consistent
with prior studies, in which it has been observed that, in
advanced CKD in the HD phase, the patient has physical
limitations, that cannot be attributed to other comorbid
conditions.41 Symptoms speciﬁc to the disease limit physical
activity, interfere with daily activities, intensify pain and its
effect on usual work, and lead the patient to make a worse
assessment of his or her state of health. Regarding mood,
probable-certain cases of anxiety comprised 36.5% of the sam-
ple, and those of depression comprised 27% of the sample.
Therefore, it should be noted that there were higher values
for abnormalities linked to anxiety than to depression. It is
known that physiological manifestations linked to anxiety
(muscle tension, sympathetic hyperarousal, parasympathetic
inhibition, etc.), when they occur for long periods of time,
may promote somatic complications such as hypertension42
and foster a greater report of physical symptoms in patients
with CKD.17 The percentages observed for the two disorders
were greater than the reported prevalence of disorders of
anxiety and depression in the general Spanish population43
and agree with prior studies on the prevalence of anxiety and
depression in patients in dialysis, which according to other
studies have been around 27%44 for anxiety and between 20%
and 30% for depression.45 Focusing on the somatic symptoms
reported, the levels shown by our sample of patients in HD are
considered to be high as compared with the results obtained,
with the same evaluation tool, in a group of healthy people
with similar sociodemographic characteristics (M = 49.30;
SD = 22.14).17
It must be emphasised that CKD and HD treatment are
highly stressful life events.20 Given the duration of the dis-
ease and its prognosis, the stress is chronic. This chronic stress
leads to anxiety and depressive states with uncertainty about
the future (dialysis or transplant for survival) and fear of los-
ing control of his or her life are essential matters.46 Anxiety is
a common problem in the kidney patient that is present since
the initiation of HD treatment11,47 and it is associated to a
lower quality of life.48 Similarly, vital stress and the limitations
imposed by a chronic disease such as CKD induce power-
lessness and loss of hope that, depending on how patients
cope with them, may lead to depression. If the depressive
symptoms of the patient in dialysis become chronic or recur-
rent, they may lead the patient to experience a substantial;3 6(3):275–282
decrease in his or her capacity to take care of day-to-day
responsibilities, to assess his or her current and future health
more negatively, to perceive more  tiredness and exhaustion,
to experience intensiﬁed body pain and to suffer a decline in
his or her social life and mental health.10
In chronic kidney diseased patients there is a high comor-
bidity between anxiety and depression.49 Given that the origin
of this anxious/depressive mood normally results from the
difﬁculty of adapting to a stressful life event, which requires
profound changes in the patient’s life (CKD itself), the most
common and correct psychiatric diagnosis is adjustment dis-
order with mixed anxiety and depressed mood.14 This study
analysed mood as comprised of the combined inﬂuence of
anxiety and depression. The results showed that a worse
mood predicts a decrease in the kidney patient’s quality of life.
These results were along the lines of other studies that have
shown the effect of emotional disturbances in CKD and their
interference with how patients think, feel and act regarding
the disease.11,14,23 Negative mood may intensify the manifes-
tations of the disease and worsen its course and progression,
as well as interfere with treatment, as it is associated with
non-adherence behaviours.12,23,39 When the renal patient has
a negative mood (anxiety and depression), he or she loses
perceived control over the disease and its treatment. This low
perceived self-efﬁcacy may derive from engagement in coun-
terproductive behaviours such as low adherence, abusive use
of medical services and improper performance of nephrology
indications and required care. These behaviours may cause
serious consequences for the patient, including malnutrition,
neuropathies, bone diseases, heart failure, etc.,50 and lead
to a more  pronounced deterioration in quality of life12 and
an increased risk of mortality.11,12,39 These results noted the
importance of early evaluation51 and treatment of negative
moods (anxiety and depression) in kidney patients, as a form
of promoting better clinical results and lowering the disease’s
interference with HRQoL. Therefore, for comprehensive care
of the kidney patient, it is very important to address negative
moods. This may modulate the disease’s interference with the
patient’s adaptive functioning.
One limitation of our study lay in the inclusion criterion
of being 60 years of age or younger, given that the population
in dialysis is generally older. This inclusion criterion reduced
the sample size. The objective of this criterion was to ensure
optimal understanding of psychological tests and therefore
achieve greater validity. Consequently, our results could not
be directly extrapolated to other age ranges. Another limita-
tion lay in the procedure used to measure somatic symptoms,
using self-report scales. It would be advisable to replicate
the results obtained with other more  direct health indica-
tors. However, the scale used to measure somatic symptoms
had good psychometric properties and validity consistent with
external measures of state of health, such as self-reports
on diseases and external criteria for health such as clinical
diagnoses,33 and such scales have become indispensable for
research in health.
In conclusion, the kidney patient’s mood (anxiety and
depression) is a powerful predictor of HRQoL, in both its phys-
ical and mental components, while somatic symptoms are
a predictor of PHC. Bearing in mind the high prevalence of
anxiety and depression in the kidney patient, their negative
1 6;3  6
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ffect on HRQoL and their importance in the determination of
ates of morbidity/mortality due to various diseases,20 these
esults have shown the need for the kidney patient to be eval-
ated and addressed preventively51 as early as the predialysis
hase to equip him or her with coping resources to man-
ge stress and the needs for adaptation imposed by his or
er disease.26,52 This may result in lower subsequent interfer-
nce by the disease with HRQoL and foster an improvement
n the course and progression of the disease, by promot-
ng adaptive behaviours associated with greater adherence to
reatment and the patient’s more  active involvement in dis-
ase management.52
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